Unreported / Non-Citable
Background
Force MOS Technology Co., Ltd. sued Alpha and Omega Semiconductor Limited (AOS) and other defendants, including Jireh, in the Northern District of California. Trial is set for December 4, 2026. After a November 3, 2026 pretrial conference, Judge P. Casey Pitts ruled on six motions in limine (Dkt. Nos. 227–232).
Force MOS asked the court to keep inequitable-conduct evidence from the jury, bar expert testimony on behalf of Jireh (which served no separate expert reports), and preclude undisclosed expert opinions from AOS employees. AOS asked the court to limit expert testimony on the terms "lateral contact layer" and "base contact layer," to exclude references to the 2024 inter partes review (IPR) of the '634 patent and the 2025 discretionary denial of IPR, and to exclude references to AOS's alleged Chinese joint ventures or affiliations.
The Court’s Holding
The court denied all three of Force MOS's motions. On inequitable conduct, AOS said it would not try that defense to the jury or argue that Force MOS or others breached the duty of candor, and the court had said it would hear the equitable defense while the jury was in recess. The court declined to police particular trial language in advance, on the understanding that AOS and its experts would not use language overly likely to suggest a breach of duties owed to the PTO, and Force MOS may object if they do. On Jireh, although it served no separate initial disclosures, damages contentions, or expert reports, barring all expert testimony on its behalf would be overly formalistic because Force MOS had fair notice of the opinions. On AOS employees, who AOS said would testify from personal knowledge of how its products and processes work, the record did not show AOS could not lay a proper foundation for lay testimony. Force MOS may object at trial to any undisclosed or inadmissible expert testimony.
The court also denied AOS's first motion. No party proposed a meaning for the two contact-layer terms at claim construction, and parties may offer evidence of plain and ordinary meaning at trial so long as they do not argue claim construction to the jury. AOS had filed no Rule 702 motion against Force MOS's disclosed expert, Dr. Dean Neikirk, so the court could not conclude his testimony should be excluded. AOS may object if Force MOS argues claim construction to the jury. The court granted AOS's second motion in part. It excluded the 2025 discretionary denial of IPR as having little probative value. It allowed the 2024 IPR, which is part of the patent file history and relevant to willfulness, because the potential prejudice did not substantially outweigh its probative value, and said it will give a mitigating instruction.
The court granted AOS's third motion only in part. It said racist or xenophobic references will not be tolerated, but found the motion overbroad because it reached incidental and potentially appropriate mentions of facts. Force MOS had argued that AOS's China-based operations bear on extraterritoriality under 35 U.S.C. § 271(f). Pursuant to the parties' agreement at the hearing, Force MOS must avoid referencing AOS's investment in a China joint venture discussed in its damages expert's report.
Key Takeaways
- Inequitable conduct remains a matter for the court, which will hear it while the jury is in recess, and the court left objections to improper trial language open.
- Jireh's lack of separate expert disclosures did not bar expert testimony on its behalf, because Force MOS had fair notice of the opinions.
- AOS employees may give lay testimony from personal knowledge, but undisclosed expert opinion remains subject to objection at trial.
- The 2024 IPR may be presented on willfulness with a mitigating instruction, while the 2025 discretionary denial is excluded as of little probative value.
- The court limited only the specific China joint-venture investment reference and otherwise refused a blanket ban on incidental China-related facts.
Why It Matters
The order favors resolving evidentiary disputes through trial objections rather than broad advance bans, particularly where a party has limited its own presentation or where disclosures gave fair notice.
It also shows the court weighing probative value under Rule 403 for the IPR evidence, separating the 2024 IPR from the 2025 denial, and distinguishing national-origin bias from incidental facts about foreign operations.